论文部分内容阅读
目的观察热毒宁注射液治疗儿童急性呼吸道感染(ARI)的临床疗效和安全性。方法将179例急性呼吸道感染患儿随机分成2组。根据临床表现均给予常规治疗,并发细菌感染者给予抗生素,观察组102例给予热毒宁注射液0.5～0.8ml/Kg加入5%葡萄糖液中静脉滴注。对照组77例给予病毒唑10～15mg/Kg加入5%葡萄糖中静脉滴注。疗程均为7d。观察两组治疗总有效率及临床症状、体征的改善情况。结果观察组总有效率95.1%;对照组总有效率85.7%。经统计学处理,两组疗效有显著差异,观察组的临床症状、体征的改善时间显著快于对照组(P<0.01)。并未见明显的毒副作用和不良反应。结论热毒宁注射液治疗儿童急性呼吸道感染起效快,疗效确切,安全性好,值得临床上推广。
Objective To observe the clinical efficacy and safety of Renduining injection in treating children acute respiratory infection (ARI). Methods 179 cases of acute respiratory infection were randomly divided into two groups. According to the clinical manifestations were given conventional treatment, bacterial infection were given antibiotics, observation group of 102 cases given Reisuoning injection 0.5 ~ 0.8ml / Kg by adding 5% glucose solution intravenous drip. The control group of 77 patients given ribavirin 10 ~ 15mg / Kg added 5% glucose intravenous infusion. Treatment are 7d. The total effective rate and clinical symptoms and signs of the two groups were observed. Results The total effective rate was 95.1% in observation group and 85.7% in control group. After statistical analysis, there was a significant difference between the two groups. The clinical symptoms and signs of the observation group were significantly faster than those of the control group (P <0.01). No obvious side effects and adverse reactions. Conclusion Revedunin injection for acute respiratory infection in children with rapid onset, effective, safe, worthy of clinical promotion.